Age group comparisons | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
18384253 | Age 24.5 ± 3, Gender ⚥ | 0.67 (mean value of the compound area) | LC-MS; GC-MS | plasma |
18384253 | Age 40.8 ± 5.6, Gender ⚥ | 1.02 (mean value of the compound area) | LC-MS; GC-MS | plasma |
18384253 | Age 55.6 ± 3.7, Gender ⚥ | 1.5 (mean value of the compound area) | LC-MS; GC-MS | plasma |
17474139 | Age 36.6 ± 5.5, Gender ⚥ | 153.2 (mmol/mol ) | H-NMR | urine |
17474139 | Age 54.5 ± 7.6, Gender ⚥ | 163.9 (mmol/mol ) | H-NMR | urine |
23701591 | Age [34-39], Gender ⚥ (American population) | 5.24 (signal intensity) | HNMR | urine |
23701591 | Age [72-84], Gender ⚥ (American population) | 3.31 (signal intensity) | HNMR | urine |
30113646 | Age 44.6 ± 14, Gender ♀ (Dutch) | 158.0 (μmol/L (baseline)) | LC-MS/MS | plasma |
30113646 | Age 44.6 ± 14, Gender ♀ (Dutch) | 110.8 (% (percentage of metabolite concentration compared with baseline (100%) per 10 year increment in age; analyses were adjusted for BMI)) | LC-MS/MS | plasma |
Linear regression | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
log2 ratio/log2(FC) | ||||
---|---|---|---|---|
PMID | Age/Age interval, Gender | Value (unit of measurement) | Method | Sample |
29090929 | Age 42 ± 12, Gender ♀ | -0.258 (log2 ratio) | NMR | blood |
29090929 | Age 41 ± 12, Gender ♂ | 0.067 (log2 ratio) | NMR | blood |